Dopamine-Modified Hyaluronic Acid (DA-HA) As A Novel Dopamine-Mimetics With Minimal Autoxidation And Cytotoxicity
Preprint
- 24 August 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Dopamine-modified hyaluronic acid (DA-HA) has been initially developed as an efficient coating and adhesion material for industrial uses. However, the biological activity and safety of DA-HA in the brain have not been explored yet. Here, we report a series of evidence that DA-HA exhibits similar functionality as dopamine (DA), but with much lower toxicity arising from autoxidation. DA-HA shows very little autoxidation even after 48-hour incubation. This is profoundly different from DA and its derivatives including L-DOPA, which all induce severe neuronal death after pre-autoxidation, indicating that autoxidation is the cause of neuronal death. Furthermore,in vivoinjection of DA-HA induces significantly lower toxicity compared to 6-OHDA, a well-known oxidized and toxic form of DA, and alleviates the apomorphine-induced rotational behavior in the 6-OHDA animal model of Parkinson’s disease. Our study proposes that DA-HA with DA-like functionalities and minimal toxicity can be an effective therapeutic substitute for L-DOPA in Parkinson’s disease.Keywords
All Related Versions
- Version 1, 2022-08-24, Research Square
- Published version: IBRO Neuroscience Reports, 15, S108.
This publication has 45 references indexed in Scilit:
- Mussel-Inspired Surface Chemistry for Multifunctional CoatingsScience, 2007
- Effects of 6‐hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line‐derived neurotrophic factorJournal of Neurochemistry, 2004
- Tyrosine Hydroxylase Is Inactivated by Catechol‐Quinones and Converted to a Redox‐Cycling QuinoproteinJournal of Neurochemistry, 1999
- The oxidant stress hypothesis in Parkinson's disease: Evidence supporting itAnnals of Neurology, 1992
- Levodopa‐induced dyskinesias in Parkinson's disease: Clinical and pharmacological classificationMovement Disorders, 1992
- Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in cultureJournal of Neuroscience Research, 1990
- The Effects of Extracellular Acidosis on Neurons and Glia in vitroJournal of Cerebral Blood Flow & Metabolism, 1989
- SYNTHETIC AMINO ACIDS AND THE NATURE OF l‐DOPA TRANSPORT AT THE BLOOD‐BRAIN BARRIERJournal of Neurochemistry, 1975
- Metabolism of dopamine and L-dopa in the human brainLife Sciences, 1973
- Neurochemical mediation of reward: A significant role for dopamine?Pharmacology Biochemistry and Behavior, 1973